Economic analysis of the Confronting COPD survey: Methodology

Michael Halpern, A. Musin, S. Sondhi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Chronic obstructive pulmonary disease (COPD) is a condition characterized by progressive airflow limitation, which causes considerable morbidity and mortality worldwide. Yet the burden of COPD is poorly recognized, and the disease remains an inadequately managed health problem. Few studies have attempted to quantify the impact of the disease on patient health, the healthcare system and society as a whole. This provided the rationale for Confronting COPD in North America and Europe, the first large-scale international survey of the burden of COPD. This paper describes how quantitative measures of healthcare resource utilization and workplace productivity loss were derived from patient responses to the Confronting COPD survey, to investigate the country-specific impact of COPD on the healthcare system and society. The aim of this analysis is to inform countries of the economic impact of the condition, and demonstrate the need for better COPD treatment to improve health and reduce the sizeable burden of this disease.

Original languageEnglish (US)
JournalRespiratory Medicine
Volume97
Issue numberSUPPL. C
StatePublished - Mar 1 2003
Externally publishedYes

Fingerprint

Chronic Obstructive Pulmonary Disease
Economics
Delivery of Health Care
Health
North America
Surveys and Questionnaires
Workplace
Morbidity
Mortality

Keywords

  • Burden
  • Chronic obstructive pulmonary disease
  • COPD
  • Cross-sectional study
  • Methodology
  • Questionaire
  • Resource utilization

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Economic analysis of the Confronting COPD survey : Methodology. / Halpern, Michael; Musin, A.; Sondhi, S.

In: Respiratory Medicine, Vol. 97, No. SUPPL. C, 01.03.2003.

Research output: Contribution to journalArticle

@article{e60715247ca24bbc8c5ec794e5c4d150,
title = "Economic analysis of the Confronting COPD survey: Methodology",
abstract = "Chronic obstructive pulmonary disease (COPD) is a condition characterized by progressive airflow limitation, which causes considerable morbidity and mortality worldwide. Yet the burden of COPD is poorly recognized, and the disease remains an inadequately managed health problem. Few studies have attempted to quantify the impact of the disease on patient health, the healthcare system and society as a whole. This provided the rationale for Confronting COPD in North America and Europe, the first large-scale international survey of the burden of COPD. This paper describes how quantitative measures of healthcare resource utilization and workplace productivity loss were derived from patient responses to the Confronting COPD survey, to investigate the country-specific impact of COPD on the healthcare system and society. The aim of this analysis is to inform countries of the economic impact of the condition, and demonstrate the need for better COPD treatment to improve health and reduce the sizeable burden of this disease.",
keywords = "Burden, Chronic obstructive pulmonary disease, COPD, Cross-sectional study, Methodology, Questionaire, Resource utilization",
author = "Michael Halpern and A. Musin and S. Sondhi",
year = "2003",
month = "3",
day = "1",
language = "English (US)",
volume = "97",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "W.B. Saunders Ltd",
number = "SUPPL. C",

}

TY - JOUR

T1 - Economic analysis of the Confronting COPD survey

T2 - Methodology

AU - Halpern, Michael

AU - Musin, A.

AU - Sondhi, S.

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Chronic obstructive pulmonary disease (COPD) is a condition characterized by progressive airflow limitation, which causes considerable morbidity and mortality worldwide. Yet the burden of COPD is poorly recognized, and the disease remains an inadequately managed health problem. Few studies have attempted to quantify the impact of the disease on patient health, the healthcare system and society as a whole. This provided the rationale for Confronting COPD in North America and Europe, the first large-scale international survey of the burden of COPD. This paper describes how quantitative measures of healthcare resource utilization and workplace productivity loss were derived from patient responses to the Confronting COPD survey, to investigate the country-specific impact of COPD on the healthcare system and society. The aim of this analysis is to inform countries of the economic impact of the condition, and demonstrate the need for better COPD treatment to improve health and reduce the sizeable burden of this disease.

AB - Chronic obstructive pulmonary disease (COPD) is a condition characterized by progressive airflow limitation, which causes considerable morbidity and mortality worldwide. Yet the burden of COPD is poorly recognized, and the disease remains an inadequately managed health problem. Few studies have attempted to quantify the impact of the disease on patient health, the healthcare system and society as a whole. This provided the rationale for Confronting COPD in North America and Europe, the first large-scale international survey of the burden of COPD. This paper describes how quantitative measures of healthcare resource utilization and workplace productivity loss were derived from patient responses to the Confronting COPD survey, to investigate the country-specific impact of COPD on the healthcare system and society. The aim of this analysis is to inform countries of the economic impact of the condition, and demonstrate the need for better COPD treatment to improve health and reduce the sizeable burden of this disease.

KW - Burden

KW - Chronic obstructive pulmonary disease

KW - COPD

KW - Cross-sectional study

KW - Methodology

KW - Questionaire

KW - Resource utilization

UR - http://www.scopus.com/inward/record.url?scp=0037372989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037372989&partnerID=8YFLogxK

M3 - Article

C2 - 12647939

AN - SCOPUS:0037372989

VL - 97

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

IS - SUPPL. C

ER -